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Abstract
The shortage of blood donor dogs in veterinary emergencies can lead to blood transfusions between animals whose blood type 
has not been identified. The antibody profile serves as a warning sign for animals that require a second blood transfusion, which 
is only advisable from compatible donor dogs. This article focuses on the determination of anti-DEA 1 antibodies using the flow 
cytometry technique in dogs that have undergone a transfusion using DEA 1-positive blood, compared to results obtained from 
crossmatching. Blood from 18 DEA 1-positive donors ranked according to the chromatographic technique was used to transfuse 
thirty-three animals with unknown blood types and which demonstrated negative crossmatching to donors. On post-transfusion 
days 7, 14, 21 and 28, 45% and 27% of the animals tested positive for the anti-DEA 1 antibody, through crossmatching and flow 
cytometry, respectively. Detecting antibodies using the flow cytometric technique has high specificity and sensitivity, while 
crossmatching methods are highly sensitive but manifest low specificity. Following the blood transfusion, animals that did not 
present as positive through crossmatching or flow cytometry were considered different from all other DEA 1-positive blood groups.
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Resumo
A escassez de cães doadores de sangue em situações de emergência na Medicina Veterinária pode levar à realização de transfusões 
de sangue entre animais que não tiveram seu tipo sanguíneo previamente determinado. O padrão de anticorpos serve como um 
sinal de alerta para animais que serão submetidos a uma segunda transfusão sanguínea, sendo esta recomendável somente se o 
sangue for proveniente de cães doadores compatíveis. Este artigo aborda a determinação de anticorpos anti-AEC 1 pela técnica 
de citometria de fluxo em cães que receberam uma transfusão utilizando sangue do grupo AEC 1 positivo, comparando-se os 
resultados com aqueles obtidos a partir de reação cruzada. Foi utilizado o sangue de 18 animais doadores do tipo AEC 1 positivo 
classificados por técnica cromatográfica, a fim de transfundir trinta e três animais com tipos sanguíneos desconhecidos e que 
demonstraram reação cruzada negativa aos doadores. Nos dias 7, 14, 21 e 28 pós-transfusão, 45% e 27% dos animais mostraram-
se positivos para os anticorpos anti-AEC 1, respectivamente, pela reação cruzada e através de citometria de fluxo. A pesquisa de 
anticorpos com o emprego da técnica de citometria de fluxo tem alta especificidade e sensibilidade, enquanto a reação cruzada, 
altamente sensível, tem baixa especificidade. Animais que não apresentaram positividade após a transfusão de sangue na reação 
cruzada e na citometria de fluxo foram considerados como pertencentes a grupos sanguíneos diferentes do AEC 1 positivo.
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Although blood transfusions can save lives, they also present 
risks and do not guarantee absolute security for transfused 
animals. Immune-mediated reactions may be caused by 
antibody interactions with antigens present in allogeneic cells 
or with proteins present in plasma (DAVIDOW, 2013; KOHN 
et al., 2014). Alloimmunization in dogs occurs when there 
is a sensitization of the immune system by other antigens. 
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Alloantibodies against dog erythrocyte antigen (DEA) 1 (1.1, 
1.2), 3, 5, 7 and Dal occur after contact with a receiver that 
does not have this blood type (BLAIS et al., 2007; KESSLER 
et al., 2010). These reactions have been described in dogs 
but have not been characterized individually, due to limited 
viability of classification procedures and lack of comparative 
studies between different blood group systems and reagents 
(BLOIS et al., 2013; ACIERNO et al., 2014). According to 
Giger (2014), the strong antigenicity of DEA 1 means that 
donor blood typing is recommended. Canine blood typing 
is based on serologic identification through agglutination 
reactions, although serum from sensitized dogs has been used 
for typing; however, these polyvalent alloantibodies vary from 
batch to batch. In theory, the ideal blood donor is a dog that is 
negative for DEA 1 (1.1, 1.2), 3, 5 and 7. However, due to the 
high population frequency of DEA 1, that includes 1.1 and 1.2, 
sampling to obtain blood from positive donors reduces the 
maintenance of the blood supply. Frequently, no assessment 
of cross-reactivity takes place to determine the occurrence of 
blood incompatibility. We note that cross-reactivity does not 
impede the sensitization of receivers (CALLAN et al., 1995; 
TOCCI; EWING, 2009).
Flow cytometry is widely applied in hematology, not 
only to identify cell phenotypes but also to detect antibodies 
(NAKAGE et al., 2005; RAMOS-VARA  et  al.,  2011). 
Ata  et  al. (2012) reported an anti-A2 antibody in 
humans that received incompatible renal transplant. This 
method has also been used in veterinary hematology to 
detect DEA 1 from antibodies using this methodology. 
Lucidi et al. (2011) researched DEA 1 in platelets but did 
not identify it while Polak et al. (2015) used the technique 
to research DEA 1 in erythrocytes using this methodology.
Since research into post-transfusion alloantibodies is 
limited, the present investigation was performed to identify 
the presence of antibodies anti-DEA 1 in dogs undergoing 
blood transfusions and compare results obtained from 
flow cytometry assay with those from crossmatching 
techniques. This study also investigated the progression 
of the production of antibodies against DEA 1 in dogs who 
received red blood cell products.
Materials and Methods
The project was approved by the Ethics Committee on 
Animal Use of the Institute of Health Sciences/Federal 
University of Bahia (Protocol No. 048/2013). The owners of 
the study animals were informed of the work methodology 
and signed the Instrument of Consent.
Eighteen applicant donor dogs whose laboratory blood 
count tests and biochemical analyses were within the normal 
range for the species were selected. The dogs also tested 
negative for the following diseases: ehrlichiosis, babesiosis, 
heartworm and leishmaniasis. Donor dog blood typing was 
performed using the chromatographic technique with the 
Alvedia® (Limonest, France) commercial kit, in line with 
the manufacturer-recommended method.
The donor group consisted of eight males and ten female 
dogs of various breeds, including eight Afghan Hounds, 
one Doberman, one Fila Brasileiro, two Labradors and six 
Belgian Malinois Shepherds, with an average age of 4.8 
years and an average weight of 34.7 kg. Selected bags of 
fresh whole blood were processed no more than two days 
following collection to prevent hemolytic storage lesion, 
in line with Duggan (2011) and McDevitt et al. (2011).
The group of recipient animals was composed of 33 
dogs recommended for blood transfusion, from a variety of 
breeds (five Rottweilers, four Yorkshire terriers, one Chow, 
one Doberman Pinscher, one Schnauzer, eight Poodles, one 
Maltese, one Golden Retriever, one Akita, two Pit Bulls, 
one Labrador Retriever and seven mongrels), 14 males and 
19 females, with an average age of 7.4 years.
Whole blood from DEA 1-classified samples was used 
for transfusion to the receiver group following compatibility 
evaluation using crossmatching, as described by Lanevschi 
and Wardrop (2001). The crossmatching results were based 
on the degree of agglutinated erythrocytes, classified 
according to Gibson (2007) with intensity varying from 
zero to four crosses. Sheep polyclonal anti-dog IgG 
AA132F FITC AbD Serotec® (Bio-Rad, Hercules, CA, USA) 
was used for the flow cytometry, which was performed 
on a Becton Dickinson FACSCalibur™ interfaced with a 
Power Macintosh computer (Apple, Salvador, BA, Brazil, 
performed at the Immunology Laboratory of the Federal 
University of Bahia) with instrument-specific computer 
software (BD CellQuest Pro™ software, Becton, Dickinson 
and Company). The steps were as follows:
•  identification of anti-DEA 1 antibodies in the 
receivers via crossmatching assay on post-
transfusion days 7, 14, 21 and 28;
•  detection of anti-DEA 1 antibodies in the receiv-
ers through flow cytometry on post-transfusion 
days 7, 14, 21 and 28;
•  comparing the antibody screening results 
from the flow cytometry with those from the 
crossmatching performed on post-transfusion 
days 7, 14, 21 and 28.
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The search for anti-DEA 1 antibodies followed the 
method used by Lucidi et al. (2011), with adjustments 
arising from the use of the erythrocyte antigen, since the 
original protocol used platelets. We maintained the test cell 
control for the detection of anti-DEA 1 antibodies using 
the same red blood cells from a DEA 1-positive dog blood 
donor. The negative control serum was obtained from an 
animal known to be DEA 1-negative, and the same sample 
was used throughout the study. The anti-DEA 1 antibody-
positive serum obtained from the receiver animal’s blood 
was added to the total polyclonal FITC-conjugated IgG. 
The cut-off point was based on a comparison of the 
negative results from the crossmatching tests with those 
from the flow cytometry.
The experimental procedure consisted of centrifuging 
2 ml of EDTA whole blood with 6 million DEA 1-positive 
erythrocytes per dL at 2200 x g for 3 minutes. The 
plasma was discarded, and the packed red blood cells 
were resuspended in the same saline volume. Two µL of 
this concentrate was then mixed with 998 µL of saline 
and homogenized by vortexing the solution. The test 
and negative control serum samples, each containing 
50 µL, were incubated at 56 °C for 10 minutes and then 
incubated with 40 µL of the diluted erythrocyte solution 
at room temperature for 30 minutes. Serum samples 
with erythrocyte suspension were washed in saline 
three times by centrifugation at 2200 x g for 3 minutes. 
Sera were added to the vials for testing and to the negative 
control, and the samples were incubated with 3 μL of 
anti-dog IgG antibody at room temperature, protected 
from light, for 30 minutes. The samples were then washed 
in saline at 2200 x g for 3 minutes. The sera in all vials 
were resuspended twice in 300 µL of saline and, finally, 
cytometry readings were made.
Statistical analyses were used to assess the results of the 
crossmatching and cytometry analyses of DEA 1 antibodies. 
The mean and standard deviations of the 33 individuals 
were surveyed over the four-week period. The comparison 
between flow cytometry was performed using ANOVA 
with the post-hoc Tukey test. Since crossmatching is an 
ordinal variable, the comparisons were analyzed using the 
Chi square test. The analyses were considered statistically 
significant at p < 0.05. All analyses were performed using the 
Statistical Package for Social Sciences (SPSS), version 17.0. 
The data were graphically displayed using Prism 5 software, 
version 5.01.
Results
A total of 9 (27%) out of the 33 tested dogs were 
positive for the presence of anti-DEA 1 antibodies using 
flow cytometry, while 15 animals (45%) from the same 
group of dogs tested positive through crossmatching with 
DEA 1-positive blood samples.
Differences were observed in the animals in varied 
crossmatching intensity in the four weeks following 
transfusion (Table 1). Table 2 shows the number of 
blood receivers, with the number of crosses representing 
crossmatching intensity over the four study weeks.
The flow cytometry analysis for individuals who 
evidenced crossmatching resulted in negative values 
ranging from 4 to 14.6 in fluorescence intensity. Samples 
that obtained values above 14.6 were considered positive; 
these values ranged from 15 to 538.99. The average number 
of anti-DEA 1 antibodies obtained in the first week was 
6.714 ± 2.436, rising to 9.431 ± 1.129 in the second week. 
In the third week, the average increased to 16.200 ± 23.70, 
while the highest value in the fourth week was 38.570 ± 
96.98 (Table 3). However, significant differences were only 
observed between the first and fourth (p = 0.026), and the 
second and fourth weeks (p = 0.038).
Figures 1 and 2 show the results of the crossmatching 
and flow cytometry assays by columns, as seen below.
Table 1 – Crossmatching (score) results for 33 post-ransfusion dogs with DEA 1-positive blood
Positive 7 days 14 days 21 days 28 days
0.121 ± 0.4846 0.576 ± 1.1465 0.939 ± 1.4129 1.333 ± 1.6708
(n) = 33 animals. Mean and Standard deviation (Pearson; p = 0.001)
Table 2 –  Intensity of crosses from the crossmatching test of 33 post-transfusion dogs with DEA 1 positive blood evaluated over 
four weeks
Crosses 7 days 14 days 21 days 28 days
0 31 26 22 19
2 2 2 4 4
3 0 5 5 4
4 0 0 2 6
(n) = 33 animals
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Figure 1 –  Evidence of the gradation of cross-reactions from 
the crossmatching compatibility test for the blood 
transfusion receiver dogs (week 0) and 7, 14, 21 
and 28 days post transfusion (weeks 1, 2, 3 and 4). 
(p = 0,001)
Figure 2 –  Evidence of the gradation of anti-DEA 1 antibodies 
from flow cytometry of the studied dogs at days 
7, 14, 21 and 28 post transfusion (weeks 1, 2, 3 
and 4). Counts is the mean fluorescent intensities. 
(p = 0,017)
Figure 3 –  Flow cytometric analysis of the dog population analyzed. Positive control means presence of antibodies anti-DEA 
1. Scatterplots of fluorescence intensity showed increased reaction antigen-antibody in the four weeks studied (A). 
The fluorescence intensity showed a clear difference between the positive reaction and the negative reaction. Negative 
control (B). A typical positive test that revealed antibodies anti-DEA 1 in the four weeks studied (C). All tests used 
forward scatter of 10000 gated events
Figure 3 has evidenced a clear distinction between 
positive and negative flow cytometric results. Positive 
control results for erythrocyte autofluorescence with the 
presence of the antibodies anti-DEA 1 and the negative 
control results for erythrocyte autofluorescence were low.
Discussion
The blood donor group represented type DEA 1-positive 
individuals. In the literature, the DEA 1 results for the 
typing parameters of the canine population in Brazil are 
extremely high (NOVAIS et al., 1999; ESTEVES et al., 2011; 
SOUZA et al., 2014). Acierno et al. (2014), observed the 
prevalence of DEA 1 among the world’s dog population 
varies between 10 and 100% and is more prevalent within 
racial groups or due to close inbreeding, compared to 
genetically mixed populations, resulting in a worldwide 
estimate of 50%. In our group of donor animals, we observed 
that all the dogs from the Belgian Malinois Shepherd and 
Table 3 –  Evaluation of number of anti DEA 1-antibodies in dogs from flow cytometry in the four weeks following DEA 1-positive 
blood transfusion
First week Second week Third week Fourth week
Flow cytometry 6.714 ± 2.436 9.431 ± 11.29 16.200 ± 23.70 38.570 ± 96.98
(n) = 33 animals. Mean and Standard deviation (ANOVA; p = 0.017)
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test demonstrated high sensitivity. However, the 
crossmatching test may provide false positives, thus 
rendering inaccurate any comparison between the two 
approaches. As described in the literature, there is no 
gold standard technique for blood typing. Flow cytometry 
was used by Acierno et al. (2014) and Polak et al. (2015) 
because of its high specificity and the possibility of 
detecting alloantibodies. The data confirm that flow 
cytometry is indeed highly specific for the detection of 
alloantibodies. However, in practice, this technique is of 
limited access, due to its high cost, while crossmatching 
remains highly accessible in clinical practice, due to its 
low cost. Despite its specificity limitations, crossmatching 
remains a viable choice for pre-transfusion testing.
Blood transfusion is a complex and varied cell therapy, and 
the most common exposure route for a high concentration 
of antigens (ZIMRING, 2013). Its effects generate direct 
alloimmunization, which is the target of the antibodies in 
this study. It is not yet clear whether weak DEA 1-positive 
dogs can trigger an alloantibody response like the response 
detected in strong DEA 1-positive dogs (ACIERNO et al., 
2014). To standardize the technique, we obtained samples of 
cells with the antigen at different DEA 1 intensities. Our flow 
cytometry survey used polyclonal (Serotec) sheep anti-dog 
antibodies, which were inherently variable and had multiple 
targets. Moreover, their agglutination reactions appeared to 
depend on antiserum concentration (ACIERNO et al., 2014; 
POLAK et al., 2015). The intensity of each serum sample we 
tested was dependent on donor DEA 1, which ranged from 
slightly to strongly positive. Each sample therefore had a 
distinct positive value , despite varying degrees of intensity.
Conclusions
The detection of antibodies and the evidence of 
crossmatching demonstrate that the flow cytometry 
technique has high specificity and sensitivity.
Animals that did not show positivity in the 
crossmatching and flow cytometry tests following blood 
transfusion were considered different from all other DEA 
1-positive blood groups.
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Afghan Hound breeds were type DEA 1. This finding 
demonstrated that the racial factor was an autosomal 
dominant trait, as reported by Iazbik et al. (2010).
Autoagglutination was observed in some patients 
during the crossmatching tests. According to Callan et al. 
(1995), incompatibility reactions in a patient with DEA 
1-negative erythrocytes suggest the existence of naturally 
occurring alloantibodies against the DEA 3, DEA 5 and 
DEA 7 types, as well as the DEA 1, representing a high 
frequency of antigenicity. In the flow cytometry study, 
the test sera were incubated at 56 °C to deactivate the 
complement system, which, given the observed interference 
from agglutination (LUCIDI et al., 2011), optimized the 
technique. In this study, we observed that the positivity 
in the crossmatching test was markedly progressive from 
the second to the fourth week, while there was a reduction 
in the cross parameter in some individuals during the 
fourth week. In subjects with a positive flow cytometry 
test, growth was evidenced numerically following the 
first week and positive progression continued until the 
fourth week, thereby confirming the technique’s high 
specificity. Some individuals were crossmatching-positive 
but flow cytometry-negative, which suggested that they 
were individuals with alloantibodies for DEA 3, 5 and 7 
or with autoantibodies and the auto agglutination typical 
of autoimmune hemolytic anemia, as mentioned by 
Blois et al. (2013).
As noted, only nine (27%) of the animals evaluated 
over the four weeks demonstrated positivity to the DEA 
1 antigen in the flow cytometry, whereas fifteen (45%) 
animals were positive in the crossmatching tests. Of these 
fifteen positive animals, seven were negative in the flow 
cytometry test. These results suggest that other erythrocyte 
antibodies were possibly involved, since other DEA types 
might have been present but were not identified in the 
study. Of the nine animals that were positive in the flow 
cytometry, only one was negative in crossmatching. This 
animal only demonstrated mild positivity (numerical 
fluorescence 20 for a cut-off of 14.7) in the third week of 
the study. This result demonstrates that crossmatching 
has a semi-quantitative nature and agglutination may 
not therefore be noticeable for a low antibody titer. All 
the animals who presented with higher fluorescence 
demonstrated positivity in the crossmatching test.
These findings highlight a relationship between the 
two techniques, thus: flow cytometry proved to be a 
high specificity technique, whereas the crossmatching 
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